| ONCT Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ONCT market cap history going back to 6/10/2019:
Also see: ONCT Shares Outstanding History and ONCT YTD Return |
ONCT Market Cap History — Oncternal Therapeutics Capitalization Over Time
As of 11/1/2024 Oncternal Therapeutics has a market cap of 4.44 million. Investors often follow the ONCT market cap history to compare the size of the company over time.
This page shows ONCT market capitalization trends over time, with 23 market cap datapoints presented, dating back to 6/10/2019.
| ONCT Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||
ONCT Historical Market Cap: -27.15% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||
| ONCT Stock Price Chart |
| About Oncternal Therapeutics Inc |
| Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on the development of oncology therapies for the treatment of patients with cancers that have critical unmet medical needs. Co.'s product candidates include ONCT-534, ONCT-808, Zilovertamab, and ONCT-216. ONCT-534 is a dual-action androgen receptor inhibitor (DAARI), for the treatment of advanced castration-resistant prostate cancer (CRPC) and other androgen receptor (AR) driven diseases. ONCT-808 is an autologous chimeric antigen receptor (CAR-T) therapy that targets ROR1 for the treatment of hematologic malignancies and solid tumors. We show 23 historical shares outstanding datapoints in our ONCT shares outstanding history coverage, used to compute ONCT market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ONCT market cap history over the course of time is important for investors interested in comparing ONCT's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ONCT versus a peer is one thing; comparing ONCT market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ONCT can fluctuate over the course of history. With this page we aim to empower investors researching ONCT by allowing them to research the ONCT market cap history. |
| ONCT Current Stock Quote |
Quotes delayed 20 minutes  Free ONCT Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| ONCT Share Performance |
| Market Cap Peers |
| Oncternal Therapeutics (ONCT) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
ONCY Market Cap History ONEM Market Cap History ONS Market Cap History ONTX Market Cap History ONVO Market Cap History OPCH Market Cap History OPGN Market Cap History OPHT Market Cap History OPK Market Cap History OPNT Market Cap History More Healthcare companies » |
ONCT Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
